MINNEAPOLIS, Oct. 23, 2013 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced that the Food and Drug Administration (FDA) has cleared the Nonin Model 3230 Bluetooth® Smart finger pulse oximeter for use in the United States. The highly accurate and reliable Model 3230 is one of the first medical devices to incorporate Bluetooth® Smart (low energy) wireless technology. Bluetooth Smart helps to facilitate simple and secure connections to Bluetooth Smart-ready devices for vital information exchange over a secure wireless connection. Nonin will demonstrate the Model 3230 at Booth #119 at Connected Health Symposium 2013 in Boston Oct. 24th and 25th.
"The FDA clearance of the Model 3230 reaffirms Nonin Medical's leadership in providing eHealth system integrators with clinically accurate and reliable devices that measure oxygen saturation and pulse rate," said Mark VanderWerf, Vice President of eHealth and OEM for Nonin Medical. The Model 3230 is designed to be used in a variety of telehealth installations for patients who rely on accurate SpO2 and pulse rate readings, especially patients who live with chronic diseases such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF) and asthma.
The Model 3230 features Nonin's exclusive CorrectCheck™ technology, which provides feedback via a digital display if the patient's finger is not placed correctly in the device. CorrectCheck is helpful since improper finger placement may lead to incorrect readings.
Another innovative feature is SmartPoint™ capture, an algorithm developed by Nonin that automatically determines when a high quality measurement is ready to be wirelessly transmitted. This helps to ensure that each reading transmitted by the Model 3230 is accurate.
"Features such as CorrectCheck and SmartPoint represent the type of innovation that Nonin OEM eHealth customers have come to expect from us," said VanderWerf. "Knowing Nonin products are providing accurate readings and transmitting those readings seamlessly will allow our OEM partners to better serve their customers, and ultimately, patients."
About Nonin Medical, Inc.
Nonin Medical, Inc. invented finger pulse oximetry and specializes in the design and manufacturing of noninvasive physiological monitoring solutions. Headquartered in Minneapolis, Minn. with an additional distribution and service center in Amsterdam, Netherlands, Nonin distributes its pulse and cerebral oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries and has more than 200 OEM partners worldwide. For more information, visit www.nonin.com.
SOURCE Nonin Medical, Inc.